Poly Medicure Limited (NSE:POLYMED)
1,868.00
+95.60 (5.39%)
Aug 11, 2026, 3:29 PM IST
Poly Medicure Revenue
Poly Medicure had revenue of 5.59B INR in the quarter ending June 30, 2026, with 38.58% growth. This brings the company's revenue in the last twelve months to 19.89B, up 17.82% year-over-year. In the fiscal year ending March 31, 2026, Poly Medicure had annual revenue of 18.75B with 12.30% growth.
Revenue (ttm)
19.89B
Revenue Growth
+17.82%
P/S Ratio
9.51
Revenue / Employee
6.45M
Employees
3,082
Market Cap
189.19B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.75B | 2.05B | 12.30% |
| Mar 31, 2025 | 16.70B | 2.94B | 21.37% |
| Mar 31, 2024 | 13.76B | 2.61B | 23.36% |
| Mar 31, 2023 | 11.15B | 1.92B | 20.82% |
| Mar 31, 2022 | 9.23B | 1.37B | 17.37% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Cipla | 280.68B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 112.30B |
| Alembic Pharmaceuticals | 77.84B |
| NATCO Pharma | 40.78B |
| Syngene International | 36.00B |
| Alivus Life Sciences | 25.90B |
Poly Medicure News
- 1 day ago - Poly Medicure Transcript: Q1 26/27 - Transcripts
- 1 day ago - Poly Medicure Quarterly report: Q1 2027 - Filings
- 1 day ago - Poly Medicure Slides: Q1 2027 - Filings
- 2 months ago - Poly Medicure cancels investor meeting scheduled for 27th May 2026 - Business Upturn
- 2 months ago - Poly Medicure Transcript: Q4 25/26 - Transcripts
- 2 months ago - Poly Medicure Quarterly report: Q4 2026 - Filings
- 2 months ago - Poly Medicure Slides: Q4 2026 - Filings
- 2 months ago - Top losers in morning trade: gujarat state petronet at ₹268.35 down 7.13%, poly medicure at ₹1,520.00 falls 4.89%, polyplex corporation at ₹914.50 down 4.88% - Business Upturn